Companies / AEON Biopharma, Inc. / Activity
Activity — AEON Biopharma, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Carter Eric G Director | Grant | Class A Common Stock | $0 | +223K +618.21% | 258,705 0.52% of shares | low |
| Jun 17, 2026 | Fischer Jost Director | Grant | Class A Common Stock | $0 | +223K +83.47% | 489,469 0.98% of shares | low |
| Jun 17, 2026 | Thunen Shelley B Director | Grant | Class A Common Stock | $0 | +223K +618.21% | 258,705 0.52% of shares | low |
| Jun 17, 2026 | Palmisano Robert J Director | Grant | Class A Common Stock | $0 | +223K +618.21% | 258,705 0.52% of shares | low |
| Mar 4, 2026 | Oh Chad Executive | Grant | Class A Common Stock | $0 | +1.3M +151.96% | 2,183,436 4.38% of shares | low |
| Feb 17, 2026 | Oh Chad Executive | Grant | Class A Common Stock | $0 | +863K +21222.93% | 866,564 1.74% of shares | low |
| Mar 4, 2026 | Wilson Alexander Blair Executive | Grant | Class A Common Stock | $0 | +1.3M +152.04% | 2,183,005 4.38% of shares | low |
| Feb 17, 2026 | Wilson Alexander Blair Executive | Grant | Class A Common Stock | $0 | +863K +23740.71% | 866,133 1.74% of shares | low |
| Mar 4, 2026 | Sy Jennifer Executive | Grant | Class A Common Stock | $0 | +926K +160.96% | 1,501,176 3.01% of shares | low |
| Feb 17, 2026 | Sy Jennifer Executive | Grant | Class A Common Stock | $0 | +575K +229083.67% | 575,251 1.15% of shares | low |
| Feb 17, 2026 | Bancroft Robert E. CEO | Grant | Class A Common Stock | $0 | +3.0M +1693.93% | 3,177,103 6.37% of shares | low |